UBS Group’s Viveon Health Acquisition Corp. VHAQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-100
Closed -$1.1K 10193
2023
Q2
$1.1K Buy
+100
New +$1.1K ﹤0.01% 8013
2023
Q1
Sell
-18,528
Closed -$197K 10883
2022
Q4
$197K Buy
18,528
+18,102
+4,249% +$189K ﹤0.01% 5464
2022
Q3
$4K Hold
426
﹤0.01% 9441
2022
Q2
$4K Buy
+426
New +$4.35K ﹤0.01% 9186
2021
Q4
Sell
-1,824
Closed -$18K 10920
2021
Q3
$18K Buy
1,824
+1,150
+171% +$11.4K ﹤0.01% 7303
2021
Q2
$7K Sell
674
-1,939
-74% -$19.2K ﹤0.01% 8372
2021
Q1
$26K Buy
+2,613
New +$26.1K ﹤0.01% 7141

Other funds holding VHAQ

UBS Group's VHAQ Position: Q3 2023 in Review

UBS Group sold out of Viveon Health Acquisition Corp. (VHAQ) in Q3 2023, closing a stake of 100 shares — an estimated $1.1K sold.

UBS Group first reported a position in VHAQ in Q1 2021 and held it in 7 quarters. The position peaked at $197K in Q4 2022. 8 funds tracked by Wall St. Rank hold VHAQ as of Q3 2023.

  • UBS Group reported no remaining Viveon Health Acquisition Corp. position as of Q3 2023 after selling out during the quarter.
  • UBS Group sold 100 Viveon Health Acquisition Corp. shares in Q3 2023, an estimated $1.1K.
  • UBS Group first reported a position in Viveon Health Acquisition Corp. in Q1 2021 and held it in 7 quarters.
  • UBS Group's Viveon Health Acquisition Corp. position peaked at $197K in Q4 2022.
  • 8 funds tracked by Wall St. Rank held Viveon Health Acquisition Corp. as of Q3 2023.

Based on UBS Group's 13F filing for Q3 2023, filed 9 Nov 2023.